Adage Capital Partners’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,086
| Closed | -$1.37M | – | 877 |
|
|
2023
Q4 | $1.37M | Buy |
29,086
+16,586
| +133% | +$783K | ﹤0.01% | 755 |
|
|
2023
Q3 | $506K | Sell |
12,500
-109,531
| -90% | -$4.43M | ﹤0.01% | 780 |
|
|
2023
Q2 | $13M | Sell |
122,031
-8,093
| -6% | -$862K | 0.03% | 516 |
|
|
2023
Q1 | $38.8M | Buy |
130,124
+75,436
| +138% | +$22.5M | 0.09% | 267 |
|
|
2022
Q4 | $18.8M | Buy |
+54,688
| New | +$18.8M | 0.05% | 442 |
|